Skip to content Skip to main menu Skip to utility menu

Drug safety notice: Hyoscine Hydrobromide (Scopoderm) 1.5mg Patches

April 29, 2024

There have been reports that some supplies of Hyoscine Hydrobromide ( Scopoderm) 1.5mg patches are unavailable, which are suspected to return in January 2025. 

Hyoscine hydrobromide patches are licensed for the prevention of travel
sickness symptoms e.g., nausea, vomiting and vertigo and used off-label for
the management of hypersalivation and drying up respiratory secretions.

Advice / Alternative
Other hyoscine hydrobromide preparations

• Hyoscine hydrobromide (Kwells) 150microgram and 300microgram tablets
can be used off label. They are taken orally, sucked, or chewed.
• In patients with swallowing difficulties
1st choice: Consider giving by parenteral injection.
2nd choice: The tablets may be sucked if the patient is able, and absorbed
through the lining of the mouth, although the level of absorption may vary,
particularly in patients with little saliva.
3rd choice: The tablets can be dissolved in water for administration via
an enteral tube, but again, absorption may vary.
4th choice: The injection has been used enterally.

For further advice, please see the guidance here – Shortage of Hyoscine hydrobromide (Scopoderm) 1.5mg patches (2)

For more information please contact the pharmacy department on ext. 5263/3783.